Latest News

Is Amazon really the only stock you need for a lifetime of wealth-building?

In a social media outburst this week, President Trump targeted music icons Taylor Swift and Bruce Springsteen, as well as the Supreme Court.

Companies such as Vertiv and CoreWeave fetch much of the attention in the AI data center market, but a smaller player called Nebius Group is quickly making a splash of its own.

Charlie Munger advised stock traders to be patient and selective, not swinging at every opportunity. His approach, along with Warren Buffett's, highlights the power of waiting for high-conviction opportunities.

Rep. Marjorie Taylor Greene (R-Ga.) has addressed rumors that President Trump discouraged her from pursuing a U.S. Senate seat.

France is witnessing a rising wave of kidnappings aimed at cryptocurrency entrepreneurs. The situation is not only damaging the country's reputation but is also becoming a political issue

With iconic brands like Lay’s, Gatorade, and Pepsi, a 4% dividend yield, and global pricing power, Pepsi continues to deliver steady income.

Howard Hughes Corporation agreed on Ackman's terms to inject capital and start buying businesses.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

UPS (NYSE:UPS) offers a high dividend yield of 6.54% with strong profitability and a reliable payout history, making it a candidate for dividend investors.

The U.S. is one of the highest-paying countries globally, but the average earnings differ significantly between industries.

QUANTA SERVICES INC (NYSE:PWR) is a quality stock with strong revenue growth, high ROIC, and solid cash flow conversion, making it a candidate for long-term investors.

Shaquille O'Neal bought his grandmother a house like he promised, showing his disciplined approach to wealth building which led to his $500M net worth.

EXELIXIS INC (NASDAQ:EXEL) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a standout in biotech. Review its full technical and fundamental strengths before considering an investment.